Helmut Hügel

Dr. Helmut Hügel

School of Applied Sciences (Chemistry), RMIT University, PO Box 2476V, Melbourne VIC 3001, Australia

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in Phytomedicine
Verified
Journal Article
Closed access
HHHelmut Hügel
Helmut Hügel
NJNeale Jackson
Neale Jackson
BMBrian May
Brian May
AZAnthony L. Zhang
Anthony L. Zhang
CXCharlie Changli Xue
Charlie Changli Xue

1 December 2009 in Molecules
Verified
Journal Article
Open access
PDF file
HHHelmut Hügel
Helmut Hügel
In the manner that very important research is often performed by multidisciplinary research teams, the applications of multicomponent reactions involving the combination of multiple starting materials with different functional groups leading to the higher efficiency and environmentally friendly construction of multifunctional/complex target molecules is growing in importance. This review will explore the advances and advantages in microwave multicomponent synthesis (MMS) that have been achieved over the last five years.

1 January 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CKChintakunta Praveen Kumar
Chintakunta Praveen Kumar
STSrinivasa reddy Telukutla
Srinivasa reddy Telukutla
PMPrathama S. Mainkar
Prathama S. Mainkar
VBVipul Bansal
Vipul Bansal
RSRavi Shukla
Ravi Shukla
HHHelmut Hügel
Helmut Hügel


17 April 2015 in Biomolecules
Verified
Journal Article
Open access
PDF file
Afsaneh PorzoorAfsaneh Porzoor
Afsaneh Porzoor
BABenjamin Alford
Benjamin Alford
HHHelmut Hügel
Helmut Hügel
DGDanilla Grando
Danilla Grando
JCJoanne Caine
Joanne Caine
Ian MacreadieIan Macreadie
Ian Macreadie
A family of 21 polyphenolic compounds consisting of those found naturally in danshen and their analogues were synthesized and subsequently screened for their anti-amyloidogenic activity against the amyloid beta peptide (Aβ42) of Alzheimer’s disease. After 24 h incubation with Aβ42, five compounds reduced thioflavin T (ThT) fluorescence, indicative of their anti-amyloidogenic propensity (p < 0.001). TEM and immunoblotting analysis also showed that selected compounds were capable of hindering fibril formation even after prolonged incubations. These compounds were also capable of rescuing the yeast cells from toxic changes induced by the chemically synthesized Aβ42. In a second assay, a Saccharomyces cerevisiae AHP1 deletant strain transformed with GFP fused to Aβ42 was treated with these compounds and analyzed by flow cytometry. There was a significant reduction in the green fluorescence intensity associated with 14 compounds. We interpret this result to mean that the compounds had an anti-amyloid-aggregation propensity in the yeast and GFP-Aβ42 was removed by proteolysis. The position and not the number of hydroxyl groups on the aromatic ring was found to be the most important determinant for the anti-amyloidogenic properties.

1 February 2014 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Open access
HHHelmut Hügel
Helmut Hügel
NJNeale Jackson
Neale Jackson
Salvia miltiorrhiza (danshen) is widely used for the clinical treatment of cerebral ischemia and cardiovascular diseases. Its diverse molecular makeup of simple and poly hydroxycinnamic acids and diterpenoid quinones are also associated with its beneficial health effects such as improved cognitive deficits in mice, protection of neuronal cells, prevention of amyloid fibril formation and preformed amyloid fibril disaggregation related to Alzheimer's disease. Whilst the in vitro studies have therapeutic promise, the anti-dementia effect/impact of danshen however depends on its absorbed constituents and pharmacokinetic properties. Both the water and lipid danshen fractions have been shown to have low oral bioavailability and at physiological pH, the polyphenolic carboxylate anions are not brain permeable. To tap into the many neuroprotective and other biological benefits of danshen, the key challenge resides in developing danshen nanopharmaceuticals, semi-synthetic pro-drug forms of its constituents to improve its biocompatability, that is, absorption, circulation in bloodstream and optimization of BBB permeability.